Statistics
Total Visits
Views | |
---|---|
The FDA‐Approved Antiviral Raltegravir Inhibits Fascin1‐Dependent Invasion of Colorectal Tumor Cells In Vitro and In Vivo | 55 |
Total Visits Per Month
January 2024 | February 2024 | March 2024 | April 2024 | May 2024 | June 2024 | July 2024 | |
---|---|---|---|---|---|---|---|
The FDA‐Approved Antiviral Raltegravir Inhibits Fascin1‐Dependent Invasion of Colorectal Tumor Cells In Vitro and In Vivo | 13 | 7 | 5 | 10 | 10 | 10 | 0 |
File Visits
Views | |
---|---|
2021 RAL cancers.pdf | 19 |
Top country views
Views | |
---|---|
United States | 18 |
United Kingdom | 14 |
Ireland | 11 |
Germany | 7 |
South Korea | 4 |
Spain | 1 |
Top cities views
Views | |
---|---|
London | 14 |
Dublin | 11 |
Frankfurt am Main | 7 |
Seoul | 4 |
Chicago | 2 |
Dallas | 1 |
Forest | 1 |
Mula | 1 |